Análisis de la acción Unum Group (UNM)UNMUnum Group

Unum Group is a provider of financial protection benefits in the United States and the United Kingdom. The Company offers disability, life, accident, critical illness, dental and vision, and other related services. Its segments include Unum US, Unum International, and Colonial Life. The Unum US segment comprises group disability, group life and accidental death and dismemberment, and supplemental and voluntary lines of business. It includes long-term and short-term disability, medical stop-loss, and fee-based service products. The Unum International segment includes insurance for group long-term disability, group life, and supplemental lines of business which include dental, individual disability, and critical illness products. The Colonial Life segment includes the accident, sickness, and disability product line, life product line, and cancer and critical illness product line. Its products are marketed to employees, on both a group and an individual basis. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).

Unum Group appears to be a good buy right now due to its current price of $91.67 being below the analyst price target of $109 from Barclays, indicating a potential upside of 18.8%. Additionally, the forward P/E ratio of 8.489 suggests the stock is undervalued compared to its earnings potential. The main risk is the cautious full-year guidance for after-tax adjusted operating income per share, which is set at $8.60 to $8.90, slightly below the consensus midpoint of $8.78, indicating potential headwinds in earnings expectations.

13 analysts cover UNM: 3 rate it Buy, 7 Hold and 3 Sell. The average price target is 94.00.